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Introduction 
Incidence and prevalence of common dysmetabolic
states, such as obesity (Ob) and diabetes, are rapidly 
increasing in western societies, most alarmingly among 
children and adolescents (1,2,3), and are associated with an
increased risk of long-term cardiovascular complications
(4,5,6).  While the biochemical link between Ob, diabetes and
future cardiovascular event is not completely elucidated, a
chronic increase in inflammatory processes is now 
considered one of the main underlying patho-physiological
mechanisms (7). 
Physical exercise has been empirically known for
decades to exert long-term protection against cardiovascular
disease (8,9). More recently, this protective effect has been
linked to  exercise-induced modulation of inflammatory
processes (10,11,12).  Acutely, i.e. in response to a single bout
of exercise, a pro-inflammatory response is generated (increase
in circulating leukocytes and in systemic concentrations of 
pro-inflammatory cytokines and chemokines), whose damaging
potential is limited by simultaneous activation of anti-
inflammatory mechanisms (13,14).  Conversely, repeated
exercise training results in significant reduction of the 
systemic inflammatory state (12,15).  The overall health
effects of exercise are therefore induced by the correct 
balance between these apparently opposed pro- and anti-
inflammatory effects (16). Our overarching hypothesis is that
in conditions characterized by a state of chronically increased
inflammation (such as Ob and diabetes) this balance may
become altered and the beneficial effects of at least some
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eliminated (17).  Consequently, gaining a thorough 
understanding of all biochemical details associated with
inflammatory regulation during exercise and of alterations, if
any, in these biochemical parameters in states of Ob and 
diabetes, appears as a necessary pre-requisite for the design
and implementation of effective preventive and/or treatment
strategies based on exercise interventions.  
Most available data in this field have been obtained from
studies in adults; extrapolation of these results to children is
conceptually inaccurate, as most metabolic and hormonal
responses differ substantially between these age groups
(18).  Further, even in adults, most studies evaluating 
inflammatory responses to exercise report measurements
before, at the end, and sometimes after the exercise challenge,
largely ignoring the time-course of these changes during 
exercise.  To fill an important knowledge gap in this area, we
have therefore designed the current study to evaluate 
concentrations and time course of a panel of key inflammatory
mediators during a standardized exercise challenge 
reproducing real-life physical activity.  The study was performed
in CL children and in children with the two most common 
pediatric dysmetabolic conditions, Ob and type 1 diabetes (T1DM).  
Methods 
Subjects and Preliminary Visit
This study was conducted at the UCI ICTS (University of
California, Irvine Institute for Clinical and Translational
Science) following UCI IRB (Institutional Review Board)
approval.  Participants were divided in three groups: Ob,
n=23 (12.5±0.5 years, 12 females), T1DM, n=23 (13.9±0.3
years, 10 females), and CL, n=20 (12.9±0.9 years, 10
females) (Table 1).
At a preliminary visit, all participants completed a 
questionnaire regarding their pubertal status and the 
information was assessed using the Tanner stages (19).
Inclusion in the Ob group was done in accordance with the 
current criteria set by the Centers for Disease Control and
Prevention (CDC), i.e., an individual age- and gender-adjusted
BMI of  ≥95th percentile.  Children in the T1DM and CL
groups had a BMI %<85th percentile.
A ramp exercise test on a braked cycle ergometer
(SensorMedics Ergoline 800S, Yorba Linda, CA) was then 
conducted to assess each individual’s cardiopulmonary 
fitness.  Work-rate was increased ~10W/min for roughly 
12-14 min until maximal tolerated workload was reached.
Maximal oxygen uptake [VO2max, or the gold standard
assessment of physical fitness, and anaerobic threshold (AT),
or the point at which additional skeletal muscular work must
be accompanied by anaerobic biochemical mechanisms] (20)
were measured by gas exchange using a standard metabolic
cart (SensorMedics VMax 229, Yorba Linda, CA).  
Main Study Day & Collection of Blood Samples
On study day, the subjects were admitted to UCI ICTS at 7
AM after an overnight fast. Upon admission, vital signs were
checked and an intravenous catheter was inserted  into the
right arm for IV infusion (insulin/dextrose for T1DM and saline
for Ob and CL subjects); a second catheter was placed into the
left arm to draw blood samples. CL and Ob subjects then 
rested for 90 minutes in order to minimize the effect of
venipuncture stress on measured variables, and then 
performed a standardized exercise challenge as described below. 
For T1DM patients whose glucose levels upon 
admission were outside the euglycemic range, glycemia was
normalized via IV insulin infusion and maintained between
4.4-6.1mM for 90 minutes prior to the start of exercise.
All subjects then performed a 30-min intermittent 
exercise test that consisted of ten, 2-minute bouts of 
constant work on a cycle ergometer with 1-minute intervals
of rest between each bout (therefore, a total of 20 min of
actual cycling and 10 min of rest).  Work-rate was adjusted to
each individual, so that it was at 50% of the difference
between the anaerobic threshold and the VO2max, or ~80%
VO2max. This procedure normalized the level of exercise
intensity to each participant’s exercise capacity. Blood 
samples were drawn immediately prior to exercise start,
after every other bout (5,6,10,12) and at end-exercise to 
analyze cytokines and plasma glucose fluctuations (Figure 1).
Laboratory Measurements
At all study time points, a 1 mL blood sample was spun
in a sterile heparin-coated microcentrifuge tube, and plasma 
glucose was measured with a Beckman Coulter Glucose II
Analyzer (Beckman Coulter, Fullerton, CA).  Following 
glucose measurement, the remaining plasma volume was
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Table 1. Demographic characteristics of the 3 experimental groups (means±SE)
Age (years) Gender (Female/Male) Height (cm) Weight (kg) BMI% VO2max (mL/min/lean kg) Tanner stage n
Ob 12.5±0.5 12/11 156.4±3 *75.8±4 *98.2±0.2 *24.3±1.2 3.0±0.3 23
T1DM 13.9±0.3 10/13 161.8±3 55.7±3 64.2±5 39.4±2.0 3.2±0.2 23
CL 12.9±0.9 10/10 151.6±4 45.8±3 56.3±5 35.7±1.3 2.8±0.4 20
Ob: obesity, T1DM: type 1 diabetic, CL: healthy control, BMI%: BMI percentile adjusted by age (in months) and gender, VO2max: volume of maximal oxygen uptake, *: p<0.0167
Ob vs. CL and T1DM in respective groupsfrozen at -800C until the day of cytokine assay.  Samples
were slowly brought to room temperature on the day of
experimental run and immunoassayed using LINCOplex
microbeads (LINCO Research, St. Charles, MO; catalog #
HSCYTO-60SK; intra-assay %CV 3.11-5.86, intra-assay %CV
2.16-14.27).  The following day, a conjugated bead
immunoassay was performed on a Luminex 200 analyzer
(Luminex Corp., Austin, TX) utilizing the MasterPlex Software
(Miraibio, Alameda, CA).   
Statistical Analysis
Demographic and circulating inflammatory markers data
of the three groups (Ob, T1DM, CL) were expressed as
group means±standard error (SE). The mixed model was
used to detect changes in measured variables during 
exercise over time; area under the curve (AUC) was used to
assess differences in variables across groups during 
exercise.  Statistical significance for baseline and AUC values
was determined using unpaired, two-tailed Student’s t-test,
with Bonferroni correction. All statistical analyses were 
performed using JMP software (SAS Institute, Cary, NC). A
p<0.0167 level after correction was considered as significant. 
Results 
Subjects
There was no difference across the three groups in terms
of age, gender distribution, height, weight, and Tanner stage:
As expected, the Ob group had significantly greater weight,
and BMI%; consequently, VO2max, expressed per total body
mass, was also reduced in this group.  If expressed per lean
body mass, however, VO2max was similar across groups
(Table 1).   
Inflammatory Mediators
Our results followed a relatively stable pattern. While the
standardized exercise challenge did not illicit an increased
inflammatory response in any of the groups, the Ob children
displayed the greatest cytokine values, and the CL children
the lowest (with only some of these differences being 
statistically significant) throughout exercise.  T1DM children
were somewhat in the middle, with values similar to the CL
group in 3/8 variables, and with some degree of elevation in
the remaining cases (Figure 2).
• Interleukin-6
Throughout exercise, in the Ob group, IL-6 mean 
concentrations were quantitatively greater (range 20.5-24.3
pg/mL) than in the control group (range 10.9-11.7 pg/mL).
The mean level of IL-6 for the T1DM group (range 17.0-18.8
pg/mL) stayed in the intermediate range between the Ob and
CL groups.   
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Figure 1. Experimental design
Subjects from all 3 groups rested for 90 min in euglycemic range after
establishment of intravenous line (T1DM required insulin and glucose
infusions to achieve euglycemia prior to the 90-min period and 
euglycemic clamp throughout the study).  The exercise paradigm 
consisted of 2-min cycling at ~80% VO2max followed by 1-min rest,
completed 10 times (30 min total, 20 min of actual cycling and 10 min
rest in between).  Blood samples were drawn immediately before and
during (every 6 min) exercise.  White bar denotes resting period; grey
bar, cycling; black arrow, blood drawn for cytokine measurements
E Ex xe er rc ci is se e   P Pr ro ot to oc co ol l
(depending on morning glucose)
0-120 min
T1DMs
Ob
CL
90 min 30 min
Glucose Normalization Stable Euglycemia
Exe (30-min)
actual exercise time; rest interval; blood sampling
Exercise
Figure 2. Elevated levels of pro-inflammatory markers in response to
exercise for the 3 experimental groups
Levels of tumor necrosis factor-α (TNF-α) and IL-2  in obesity (Ob)
(grey circle), type 1 diabetic (T1DM) (black circle), and healthy control
(CL) (white circle) groups at baseline and during exercise. Data are
expressed as means±SE in the 3 groups, Ob vs. CL at baseline
*(p<0.0167); †(p<0.0167), AUC: Ob vs. CL; ** (p<0.0167), Ob vs. CL
and T1DM; ‡(p<0.0167), AUC: Ob vs. CL and T1DM
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In the Ob group, TNF-α was significantly greater (range 
3.2-3.6 pg/mL) than in the CL and T1DM children (ranging
from 2.1-2.3 pg/mL, 2.2-2.6, respectively, p<0.0167), and
remained significantly elevated throughout exercise (AUC:
Ob, 84.6±7.5; CL, 54.1±5.6; T1DM, 57.8±6.2,  p<0.0167).  
For IL-2, the Ob group had significantly higher values
(range 7.1-11.1 pg/mL) than the T1DM (range 3.2-4.3 pg/mL)
and CL (range 3.3-4.4 pg/mL) groups (p<0.0167).  
• Other Pro-Inflammatory Mediators (IL-5, IL-8, IL-13)
In the Ob and T1DM groups, the levels of IL-5, IL-8, and 
IL-13, pro-inflammatory mediators were elevated as 
compared to the CL group, albeit no significance was 
detected.  For each experimental group, there was 
consistency from baseline throughout exercise for IL-5 and
IL-13, in that the amount of oxidative stress markers that
were released were shown to be higher in the Ob children
compared to the T1DM and CL subjects.  For IL-5, levels in
the Ob group stayed between 0.6-0.7 pg/mL, whereas those
in the T1DM and CL groups were between 0.2-0.5 pg/mL.
As for IL-8, the Ob group expressed levels between 6.4-7.7
pg/mL, very similar to those of the T1DM group.  However,
it is important to note that the CL group showed lower val-
ues in all three assays of these cytokines.  
• Anti-Inflammatory Mediators (IL-10 and IL-4)
The pattern observed for IL-10 showed elevated values in
the Ob group. Values in T1DM subjects were about the same
as CLs.  The Ob group fluctuated between 8.7-12.7 pg/mL
and the T1DM and CL were between 5.4-7.6 pg/mL.
However, as to IL-4, cytokine levels were elevated in the Ob
and T1DM groups as opposed to the CLs. The levels in the
CL group stayed low between 110.6-122.1 pg/mL, whereas
those in the T1DM and Ob groups were between 203.5-
249.2 pg/mL. No significant differences were detected
among the groups in  anti-inflammatory mediator values
(Figure 3).
Discussion 
Using a conjugated micro-bead immunoassay and an 
exercise model representative of daily physical activity, we
identified a number of differences in inflammatory mediator
concentrations between CL, Ob and T1DM children.  All 8 
tested cytokines were quantitatively elevated in the Ob
group as compared to CLs, reaching statistical significance
for TNF-α and IL-2. T1DM subjects also displayed some
degree of elevation, which was, however, as marked as in
the Ob group only for IL-5 and IL-8; for the other measured
variables, the elevation was either modest or, in the case of
TNF-α and IL-2, completely absent.  While some prior 
studies had focused on similar issues, information had been
fragmented by the fact that individual variables and subject
groups were studied separately and with different protocols,
rendering quantitative comparison problematic. To our
knowledge, ours is the first comprehensive report of a broad
cytokine panel tested simultaneously in children, during a
standardized exercise challenge, in these three conditions. 
Our results are consistent with prior reports of elevated
inflammatory status in these patient groups. Several authors
reported a positive correlation between Ob/visceral 
adiposity and several inflammatory markers, including TNF-α,
IL-6, and C-reactive protein, both in adults (21) and children
(22,23).  Conversely, a significant decrease in systemic levels
of inflammatory markers were reported in Ob subjects after
weight loss (24,25). Further, in young T1DM subjects,
Erbagci et al (26), among others, reported elevated TNF-α
and IL-8 in newly diagnosed (<1year) patients, and elevated
IL-2 levels in all T1DM subjects when compared to age- and 
gender-matched CLs.  Several previous studies from our 
laboratory have also confirmed the presence of elevated 
levels of IL-6 in T1DM children, relative to CLs, both at rest
and during exercise (27), and correlated the degree of the 
IL-6 elevation with the magnitude of hyperglycemic episodes
to which subjects had been exposed during the previous
hours and days (28,29). Taken together, and considering the
now well-established link existing between chronically
increased inflammatory status and long-term development of 
cardiovascular complications, our observations in Ob and
T1DM subjects indicate that some of the pathogenetic
mechanisms leading to these complications may be already
active at the very early stages of these conditions. 
While in general inflammatory status appeared increased
in both our groups of patients, the pattern of elevation of 
individual inflammatory mediators was clearly different
between T1DM and Ob groups, with the latter group 
displaying an overall considerably greater level of activation of
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Figure 3. Elevated levels of anti-inflammatory markers in response to
exercise for the 3 experimental groups 
Levels of anti-inflammatory cytokines, IL-10 and IL-14 in obesity (Ob)
(grey circle) , type 1 diabetic (T1DM) (black circle), and healthy control
(CL) (white circle) groups at baseline and during exercise.  Data are
expressed as means±SE
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such a difference did not come as a surprise. Inflammatory 
homeostasis encompasses an extremely complex series of
processes, regulated by hundreds, possibly thousands of 
different components, only some of which may be specifically
activated in response to individual stimuli (30,31,32,33,34). In
Ob, for instance, while occasional exacerbations may 
be induced by acute hyperlipidemia or other overlapping
pathologies, a chronic, subclinical but pro-inflammatory 
stimulus is provided by the adipose tissue itself, within which
a large number of activated macrophages continuously
secrete chemokines and cytokines (35). On the other hand,
in T1DM it is still debated whether presence of the disease
per se implies pro-inflammatory activation (36). In these
patients, however, acute, repeated and frequent pro-
inflammatory signals are created with each hyperglycemic
episode (37,38), the magnitude, duration and repetition 
pattern of which may determine the degree and type of
involved inflammatory process (28,39). In these patients, as
in the group of T1DM subjects in our study, prior 
hyperglycemia had not been brought under control, and it is
likely that a mixed level of pro-inflammatory activation 
existed across subjects, possibly resulting in the less pro-
nounced alterations that were observed as compared to the
Ob group.  It is therefore possible, although it would have to
be confirmed with a separate set of studies, to speculate that
T1DM recently exposed to severe hypoglycemia would 
display an inflammatory response as pronounced, if not even
greater, than that observed in Ob children. Differences
across subject groups may also have been amplified by the 
fact that exercise causes an independent, albeit physiological,
rise in inflammation, if superimposed to an already enhanced
inflammatory milieu (such as in the Ob children), and that 
this  may have unevenly enhanced activation of some of its
components. 
Central to this study was the exercise protocol, which
was specifically developed in our laboratory for use in 
children, and has now been applied thousands of times in a
variety of experimental settings and different study 
populations. The controlled exercise work-rate (~ 80% of
VO2max, a definitely intense level of exertion), and the 
1-minute breaks in between each 2-minute bout were meant
to reproduce as much as possible a real-life exercise 
challenge (e.g. a soccer or basketball practice, or a dance 
session) while eliciting a strong and widespread cytokine
response.  Cycle ergometry was chosen over treadmill 
running due to the closest correlation obtainable with the 
former technique between selected workload and work 
actually performed by the subject. It also important to note
that for exercise responses to be meaningfully compared
across different experimental groups, the level of fitness
should be comparable across study participants.  In our
study, CLs and T1DM patients indeed displayed similar
VO2max/kg values, while in the Ob group, these were 
substantially lower (Table 1) due to their greater body weight.
If normalized by lean body mass, however, which is a better
predictor of exercise capacity than total body weight,
VO2max was similar across all three groups.  The fact that
the relative intensity of the exercise challenge was the same
in all groups was also testified by a similar exercise-induced
increase in plasma lactate. A separate set of issues 
concerned our T1DM subjects, for whom optimal glycemic
control before and during exercise was an indispensable 
prerequisite to data interpretation (had they exercised in
hyperglycemic conditions, in fact, it would have been 
impossible to determine what would have caused the 
elevated cytokine levels).   As stated in the Methods section,
we therefore included in the study design a stabilization 
period of a minimum of 90-minute before exercise, in which
plasma glucose had to be in the normal range. If a T1DM
patient displayed elevated glucose levels at admission,
insulin was infused intravenously, plasma glucose was
checked repeatedly until it reached the normal range, (80-110
mg/dL), which in some instances took up to two hours; then
the 90 min of stabilization was started, and exercise was 
performed only after all this was completed.  Applying these
steps in methodology, our laboratory has achieved, safely
and effectively, stable euglycemic conditions before, during
and after exercise in hundreds of human studies over the last
decade (23,40,41,42,43).  
The authors are aware that the choice of using a 
conjugated micro-bead assay to determine cytokine 
concentrations, as opposed to the standard ELISA 
technique, may be prone to controversy, as results
obtained with this methodology were at times found to vary
in absolute values when matched with gold-standard 
techniques. Other studies, however, reported very good
correlations (44), and our laboratory has independently 
validated these results by running matching ELISA tests on
a subset of study samples, with excellent agreement.
Further demonstration of the quality of our data was the
fact that within the multiple time points obtained from each
subject, the data was very consistent.  Also, considering
that the study subjects were children, a definitely 
vulnerable population, the volume of total blood drawn was
an issue, and the ability of the assay to simultaneously
measure a large number of values in a single sample of a
volume of a fraction of 1 mL rendered the conjugated
micro-bead assay especially well suited for our 
experiments. It should also be noted that, to further minimize
the potential for variability, all assays were performed at the
same time and using materials from the same company.
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implications for the design and implementations of specific
exercise guidelines in Ob and diabetes. While it is 
relatively well established that exercise provides long-term 
cardiovascular protection, and that modulation of inflammatory
processes likely plays a key role in this effect, the 
biochemical details of these interactions remain undefined.
Stating that “inflammation is increased” in Ob and diabetes
is obviously not enough to provide workable conceptual
bases for specific exercise strategies (45). Our study 
demonstrates that different components of the 
inflammatory cascade may be activated in different groups of
subject.  We can safely assume that additional differences
may exist for yet other common chronic conditions, as well
as with use of exercise formats of different type, intensity,
duration, or repetition pattern. The next logical steps 
therefore appear to be first identifying all individual 
inflammatory mediators involved in each exercise format,
and then the possible alterations of their activation pattern
induced by specific pathological conditions.  Only then we
will be able to truly develop optimal exercise regimens, 
differently calibrated for narrowly focused groups of subjects.
We believe our results represent a small step in this direction. 
In summary, we are reporting the observation that 
circulating concentrations of pro- and anti-inflammatory
cytokines were greater in Ob children, and to a lesser extent
in T1DM patients, as compared to CLs.  As physical exercise
is advocated as a key management strategy in these 
conditions, but chronic inflammation is also considered a
leading cause of their long-term cardiovascular
complications, our results raise the issue of what exercise
type and formats should be implemented to optimize health
benefits in situations characterized by a chronically elevated,
subclinical inflammatory status. 
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